Effect of ras inhibition in hematopoiesis and BCR/ABL leukemogenesis

Journal of Hematology and Oncology

Volumn 1, Issue 1, 2008, Pages

  Baum, Karina J ^a,b   Ren, Ruibao ^a  

^a BRANDEIS UNIVERSITY   (United States)

^b BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; RAS PROTEIN;

ANIMAL; ARTICLE; BONE MARROW CELL; CELL STRAIN 3T3; CHRONIC MYELOID LEUKEMIA; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEMATOPOIESIS; HUMAN; METABOLISM; MOUSE; MUTATION; T LYMPHOCYTE;

ANIMALS; BONE MARROW CELLS; FUSION PROTEINS, BCR-ABL; GENE EXPRESSION REGULATION, LEUKEMIC; HEMATOPOIESIS; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MICE; MUTATION; MYELOID CELLS; NIH 3T3 CELLS; RAS PROTEINS; T-LYMPHOCYTES;

EID: 77953050738     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-1-5     Document Type: Article

References (35)

1. Ulku AS, Der CJ: Ras signaling, deregulation of gene expression and oncogenesis. Cancer Treat Res 2003, 115:189-208.
2. Barbacid M: ras genes. Annu Rev Biochem 1987, 56:779-827.
3. Hancock JF: Ras proteins: different signals from different locations. Nat Rev Mol Cell Biol 2003, 4(5):373-384. (Pubitemid 36565569)
4. Hingorani SR, Tuveson DA: Ras redux: rethinking how and where Ras acts. Curr Opin Genet Dev 2003, 13(1):6-13. (Pubitemid 36143921)
5. Esteban LM, Vicario-Abejon C, Fernandez-Salguero P, FernandezMedarde A, Swaminathan N, Yienger K, Lopez E, Malumbres M, McKay R, Ward JM, et al.: Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development. Mol Cell Biol 2001, 21(5):1444-1452. (Pubitemid 32156364)
6. Umanoff H, Edelmann W, Pellicer A, Kucherlapati R: The murine Nras gene is not essential for growth and development. Proc Natl Acad Sci USA 1995, 92(5):1709-1713.
7. Johnson L, Greenbaum D, Cichowski K, Mercer K, Murphy E, Schmitt E, Bronson RT, Umanoff H, Edelmann W, Kucherlapati R, et al.: K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev 1997, 11(19):2468-2481. (Pubitemid 27438829)
8. Koera K, Nakamura K, Nakao K, Miyoshi J, Toyoshima K, Hatta T, Otani H, Aiba A, Katsuki M: K-ras is essential for the development of the mouse embryo. Oncogene 1997, 15(10):1151-1159. (Pubitemid 27429618)
9. Bos JL: ras oncogenes in human cancer: a review. Cancer Res 1989, 49(17):4682-4689. (Pubitemid 19213607)
10. Ren R: Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer 2005, 5(3):172-183. (Pubitemid 40314949)
11. Pear WS, Miller JP, Xu L, Pui JC, Soffer B, Quackenbush RC, Pendergast AM, Bronson R, Aster JC, Scott ML, et al.: Efficient and rapid induction of a chronic myelogenous leukemia-like myelopro-liferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood 1998, 92(10):3780-3792. (Pubitemid 28525205)
12. Zhang X, Ren R: Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia. Blood 1998, 92(10):3829-3840. (Pubitemid 28525209)
13. Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N, Batzer A, Rabun KM, Der CJ, Schlessinger J, et al.: BCR-ABLinduced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 1993, 75(1):175-185. (Pubitemid 23306031)
14. Puil L, Liu J, Gish G, Mbamalu G, Bowtell D, Pelicci PG, Arlinghaus R, Pawson T: Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway. EMBO J 1994, 13:764-773. (Pubitemid 24057507)
15. He Y, Wertheim JA, Xu L, Miller JP, Karnell FG, Choi JK, Ren R, Pear WS: The coiled-coil domain and Tyr177 of bcr are required to induce a murine chronic myelogenous leukemia-like disease by bcr/abl. Blood 2002, 99(8):2957-2968. (Pubitemid 34525386)
16. Million RP, Van Etten RA: The Grb2 binding site is required for the induction of chronic myeloid leukemia-like disease in mice by the Bcr/Abl tyrosine kinase. Blood 2000, 96(2):664-670. (Pubitemid 30463389)
17. Zhang X, Subrahmanyam R, Wong R, Gross AW, Ren R: The NH(2)-terminal coiled-coil domain and tyrosine 177 play important roles in induction of a myeloproliferative disease in mice by Bcr-Abl. Mol Cell Biol 2001, 21(3):840-853. (Pubitemid 32104732)
18. Sattler M, Mohi MG, Pride YB, Quinnan LR, Malouf NA, Podar K, Gesbert F, Iwasaki H, Li S, Van Etten RA, et al.: Critical role for Gab2 in transformation by BCR/ABL. Cancer Cell 2002, 1(5):479-492. (Pubitemid 41039128)
19. Sawyers CL, McLaughlin J, Witte ON: Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene. J Exp Med 1995, 181:307-313.
20. Matallanas D, Arozarena I, Berciano MT, Aaronson DS, Pellicer A, Lafarga M, Crespo P: Differences on the inhibitory specificities of H-ras, K-ras, and N-ras (N17) dominant negative mutants are related to their membrane microlocalization. J Biol Chem 2003, 278(7):4572-4581. (Pubitemid 36800954)
21. Prior IA, Hancock JF: Compartmentalization of Ras proteins. J Cell Sci 2001, 114(Pt 9):1603-1608. (Pubitemid 32454658)
22. Prior IA, Muncke C, Parton RG, Hancock JF: Direct visualization of Ras proteins in spatially distinct cell surface microdomains. J Cell Biol 2003, 160(2):165-170. (Pubitemid 36254950)
23. Hawley RG: High-titer retroviral vectors for efficient transduction of functional genes into murine hematopoietic stem cells. Ann N Y Acad Sci 1994, 716:327-330. (Pubitemid 24228125)
24. Cuenco GM, Ren R: Cooperation of BCR-ABL and AML1/ MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia. Oncogene 2001, 20(57):8236-8248. (Pubitemid 34038211)
25. Gross AW, Zhang X, Ren R: Bcr-Abl with an SH3 deletion retains the ability To induce a myeloproliferative disease in mice, yet c-Abl activated by an SH3 deletion induces only lymphoid malignancy. Mol Cell Biol 1999, 19(10):6918-6928. (Pubitemid 29441874)
26. Rosenberg N, Baltimore D: A quantitative assay for transformation of bone marrow cells by Abelson murine leukemia virus. J Exp Med 1976, 143(6):1453-1463.
27. Liu X, Constantinescu SN, Sun Y, Bogan JS, Hirsch D, Weinberg RA, Lodish HF: Generation of mammalian cells stably expressing multiple genes at predetermined levels. Anal Biochem 2000, 280(1):20-28. (Pubitemid 30210807)
28. Hardy RR, Carmack CE, Shinton SA, Kemp JD, Hayakawa K: Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med 1991, 173(5):1213-1225.
29. Iritani BM, Forbush KA, Farrar MA, Perlmutter RM: Control of B cell development by Ras-mediated activation of Raf. Embo J 1997, 16(23):7019-7031. (Pubitemid 27520802)
30. Swan KA, Alberola-Ila J, Gross JA, Appleby MW, Forbush KA, Thomas JF, Perlmutter RM: Involvement of p21ras distinguishes positive and negative selection in thymocytes. Embo J 1995, 14(2):276-285.
31. Zhang J, Socolovsky M, Gross AW, Lodish HF: Role of Ras signaling in erythroid differentiation of mouse fetal liver cells: functional analysis by a flow cytometry-based novel culture system. Blood 2003, 102(12):3938-3946. (Pubitemid 37486974)
32. Braun BS, Tuveson DA, Kong N, Le DT, Kogan SC, Rozmus J, Le Beau MM, Jacks TE, Shannon KM: Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder. Proc Natl Acad Sci USA 2004, 101(2):597-602. (Pubitemid 38084682)
33. Chan IT, Kutok JL, Williams IR, Cohen S, Kelly L, Shigematsu H, Johnson L, Akashi K, Tuveson DA, Jacks T, et al.: Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease. J Clin Invest 2004, 113(4):528-538. (Pubitemid 38542502)
34. Schwaller J, Parganas E, Wang D, Cain D, Aster JC, Williams IR, Lee CK, Gerthner R, Kitamura T, Frantsve J, et al.: Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/ JAK2. Mol Cell 2000, 6(3):693-704.
35. Teglund S, McKay C, Schuetz E, van Deursen JM, Stravopodis D, Wang D, Brown M, Bodner S, Grosveld G, Ihle JN: Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 1998, 93(5):841-850. (Pubitemid 28257589)